Lack of serologic evidence for prevalent simian virus 40 infection in humans.
about
Simian virus 40 in humansAssociation of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinomaMesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40SV40 and human cancer: a review of recent data.Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder.Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses.Serologic evidence of frequent human infection with WU and KI polyomaviruses.Complete nucleotide sequence of polyomavirus SA12.Seroprevalence of trichodysplasia spinulosa-associated polyomavirusInvestigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirusThe novel human polyomaviruses HPyV6, 7, 9 and beyond.JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein levelAntibodies reacting with Simian virus 40 mimotopes in serum samples from patients with thalassaemia major.Persistence and pathogenesis of the neurotropic polyomavirus JCMolecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort.Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.Interaction between Simian Virus 40 Major Capsid Protein VP1 and Cell Surface Ganglioside GM1 Triggers Vacuole Formation.Seroprevalence and cross-reactivity of human polyomavirus 9.Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence.High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.Molecular and clinical perspectives of polyomaviruses: emerging evidence of importance in non-kidney transplant populations.Role of simian virus 40 in cancer incidence in solid organ transplant patients.Merkel cell carcinoma: a virus-induced human cancerThe role of polyomaviruses in human disease.Polyomaviruses of nonhuman primates: implications for research.Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme.Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein.Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.Serological cross-reactivity between human polyomaviruses.The human JC polyomavirus (JCPyV): virological background and clinical implications.Polyomavirus BK and prostate cancer: a complex interaction of potential clinical relevance.High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma.Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects.Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40.Significant association between human osteosarcoma and simian virus 40.Viruses and collapsing glomerulopathy: a brief critical review.
P2860
Q21202825-D2FA512B-32C1-45BE-A404-7B8322D2361DQ24644897-2AA7D94A-2423-459E-A83F-CF18B2EF7B80Q28392429-31F99CAF-E9D6-4200-AA91-FEE958D28B2EQ31080786-7CD4CAFD-8D02-46E5-ADBC-9960B6CF0519Q33267775-1C823007-D01B-408A-9740-3662C3B0AA34Q33591211-B7C7AE93-3CF0-4B67-B2B1-DEDD72310507Q33628721-1B672731-4069-40FB-9BC9-B42AE11441C3Q34045700-352B07DA-576A-4142-AE1E-0993766A9A63Q34204699-E6A02C96-F4D4-498E-A9D2-6C62A2A6D7AAQ34263748-9FCDACEE-F0A6-4BDF-B19B-E24189716DF2Q34321814-CBBF6AD7-C3D9-4254-BF48-C457B8B5276BQ34343557-DFD67E11-35AE-4F98-8762-5FFA182E5BEEQ34351212-13AAA224-9305-4738-926F-AD1C05C9DA58Q34416300-D2DF135D-A88E-4FDA-9BF8-49FFF06B467BQ34459843-DDF1E893-2F7C-4E28-A2AA-BB1484B99509Q34572298-0E8B1BF7-9EE4-46AF-B363-5EB001F4C7B3Q34698094-8EF63FC2-ED60-4272-81B0-25F33F3C1374Q34786760-936378DD-E9C3-4DC6-8C8C-7B35E782FA7BQ35868060-5D95A4F2-3F3C-4F1A-B4F6-A5B1A8C73E1BQ35885632-52623F44-1BFB-4512-89AB-940E138222EDQ35967124-DB873F31-C369-4687-87AF-368544DEBD71Q36148032-6F425C5C-C989-44F3-89F2-6BC79A39E9BFQ36276355-C12FC6E6-BEB5-460A-B137-C783D98D9598Q36397962-53D6FDAD-C954-4400-B8F8-72627EE85E7EQ36605107-E66FBFD0-99B3-4187-A93D-3000E007D9E8Q36614218-49986CA1-9A12-4858-8CA0-E4086B36978AQ37067101-78D62C8A-C30D-4651-9CA0-9C0858CD5776Q37141010-4A079A36-23EA-4F3F-9374-C1A66038C4B6Q37606003-6789A4BE-7E7B-4676-A633-809C343598CFQ37641226-04F46F68-6723-45F6-9F8E-42B80DC0FF0DQ37743114-9A22A4AC-EB9E-4F02-A4EB-D32A9CE349ECQ37982013-249C1927-0DA9-4400-A804-C5051444ADA0Q38104692-B0E814C8-9977-4CE2-87BC-63F199C0DFF2Q38115572-14B56445-92F1-46D8-A037-C7EC2F439441Q38574112-18AFE673-CFC0-4FC1-A943-AF4522D8208EQ38813350-DB2BB4AF-7B97-416E-9EB2-DA7A13299FD1Q40720491-74FEBDF7-D728-4D52-B323-D17B43AD306FQ41069112-4A19C8A6-1DD4-48D3-B388-63988CDD15AFQ42181980-C6EA6B88-549A-4699-B027-DF56593B2F55Q43101728-57CB07BE-C26F-4F71-A5B1-986269BC8D2F
P2860
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@en
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@nl
type
label
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@en
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@nl
prefLabel
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@en
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@nl
P2093
P356
P1476
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
@en
P2093
Denise A Galloway
Greg C Wipf
Joseph J Carter
Margaret M Madeleine
Pam A Pipkin
Philip D Minor
Robert L Garcea
P304
P356
10.1093/JNCI/DJG074
P407
P577
2003-10-01T00:00:00Z